• Explore /
  • Poster
  • / A phase I-II study to evaluate safety and efficacy of the combination of niraparib plus cabozantinib in patients with advanced kidney/urothelial carcinoma.

A phase I-II study to evaluate safety and efficacy of the combination of niraparib plus cabozantinib in patients with advanced kidney/urothelial carcinoma.

Abstract Poster

Authors

null

Albert Font Pous

Institut Català d’Oncologia, Hospital Universitari Germans Trias i Pujol (HUGTiP), Badalona, Spain

Albert Font Pous , Miguel Angel Climent Duran , Ignacio Duran , Begona Mellado , Jesus Paramio , Francisco X. Real , Jose Luis Ramirez , Juan Luis Sanz , Daniel E. Castellano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT03425201

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr TPS501)

DOI

10.1200/JCO.2019.37.7_suppl.TPS501

Abstract #

TPS501

Poster Bd #

N11

Abstract Disclosures

Similar Posters

First Author: Daniel E. Castellano

First Author: Daniel E. Castellano

First Author: Marcia Hall

First Author: Abhishek Tripathi